Consolidation Immunotherapy in Unresectable Early NSCLC: PACIFIC Study

Ben Levy, MD, reviews the 5-year update and clinical implications of the PACIFIC study which evaluated consolidation immunotherapy in unresectable early-stage NSCLC.

Related Keywords

,Recent Updates ,Translating Evidence ,Clinical Practice ,Unresectable Early ,Nsclc ,Early Nsclc ,Non Small Cell Lung Cancer ,Asco 2023 ,Localized Disease ,Presection ,Surgery ,Staging ,Chemoimmunotherapy ,Immunotherapy ,Ohio ,Molecular Testing ,Liquid Biopsy ,Tissue Biopsy ,Ngs Testing ,Egfr ,Talk ,